Universitätsklinikum Bonn

Ongoing outbreak of maternal parvovirus B19 infections in Germany since end of 2023: consequence of COVID-19 pandemic? (2025) Jiménez Cruz J, Axt-Fliedner R, Berg C, Faschingbauer F, Kagan KO, Knabl J, Lauten A, et al. Journal article Post-marketing Experience with Cenobamate in the Treatment of Focal Epilepsies: A Multicentre Cohort Study (2025) Strzelczyk A, von Podewils F, Hamer H, Knake S, Rosenow F, Klotz KA, Kurlemann G, et al. Journal article A Radiologist’s Guide to IDH-Wildtype Glioblastoma for Efficient Communication With Clinicians: Part I–Essential Information on Preoperative and Immediate Postoperative Imaging (2025) Vollmuth P, Karschnia P, Sahm F, Park YW, Ahn SS, Jain R Journal article, Review article Therapy response prediction of focal cortex stimulation based on clinical parameters: a multicentre, non-interventional study protocol (2025) Kalousios S, Hesser J, Dümpelmann M, Baumgartner C, Hamer H, Hirsch M, Imbach L, et al. Journal article Phase i study of intratumoral administration of CV8102 in patients with advanced melanoma, squamous cell carcinoma of the skin, squamous cell carcinoma of the head and neck, or adenoid cystic carcinoma (2025) Eigentler T, Thomas I, Samoylenko I, Erdmann M, Heinzerling L, Ochsenreither S, Krauss J, et al. Journal article Efficacy and safety of guselkumab in European patients with palmoplantar pustulosis: A multi-center, single-arm clinical trial (GAP study) (2025) Wilsmann-Theis D, Patt S, Pinter A, Gerdes S, Magnolo N, Németh R, Schmitz J, et al. Journal article Das Forum Junge Radiologie in der Deutschen Röntgengesellschaft (2025) Balks MF, Bayerl N, Berger J, Erley J, Gotta J, Heimer MM, Hoffmann E, et al. Journal article The modified Glasgow Prognostic Score (mGPS) can guide decisions for immunotherapy treatment beyond progression. (2025) Saal J, Eckstein M, Ritter M, Brossart P, Hölzel M, Grünwald V, Klümper N Journal article Trio Exome Sequencing in VACTERL Association (2025) Ćomić J, Tilch E, Riedhammer KM, Brugger M, Brunet T, Eyring K, Vill K, et al. Journal article Idecabtagene vicleucel or ciltacabtagene autoleucel for relapsed or refractory multiple myeloma: An international multicenter study (2025) Merz M, Albici AM, von Tresckow B, Rathje K, Fenk R, Holderried T, Müller F, et al. Journal article